Tweet
Grapiprant is a new class of drug for treating ‘pain associated with mild to moderate osteoarthritis in dogs’. A balanced appraisal of this new drug is now available from Veterinary Prescriber in the form of a succinct online learning module. Anyone who does the module will:·
- Understand the pharmacology of grapiprant.
- Know the clinical evidence on the efficacy and safety of grapiprant.
- Be aware of what is known about how grapiprant compares with NSAIDs.
- Understand what is meant by intention to treat and per protocol analysis in clinical trials result analysis.
- Understand what is meant by the number needed to treat and its relevance to clinical practice.
- Be able to make up their own minds about whether and how to use it.
Veterinary Prescriber's e-modules are of the highest quality: evidence based, peer reviewed and independent of the pharmaceutical industry costing only £9.95 per month (including VAT) rolling contract, cancel anytime.
Veterinary Prescriber is the key to prescribing excellence.
To find out more or to arrange to see the module contact: Carl Russell on 01962 860004 or visit https://cpd.veterinaryprescriber.org/